Extent of Surgery for Papillary Thyroid Cancer Is Not Associated With Survival An Analysis of 61,775 Patients

被引:353
作者
Adam, Mohamed Abdelgadir [1 ]
Pura, John [2 ]
Gu, Lin [2 ]
Dinan, Michaela A. [3 ]
Tyler, Douglas S. [1 ]
Reed, Shelby D. [3 ]
Scheri, Randall [1 ]
Roman, Sanziana A. [1 ]
Sosa, Julie A. [1 ,3 ]
机构
[1] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[2] Duke Univ, Dept Biostat, Durham, NC 27710 USA
[3] Duke Clin Res Inst, Durham, NC USA
关键词
National Cancer Database; overall survival; papillary thyroid cancer; thyroid lobectomy; total thyroidectomy; DIFFERENTIATED CARCINOMA; ONE INSTITUTION; UNITED-STATES; DATA-BASE; LOBECTOMY; IMPACT; CARE;
D O I
10.1097/SLA.0000000000000925
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Objective: To examine the association between the extent of surgery and overall survival in a large contemporary cohort of patients with papillary thyroid cancer (PTC). Background: Guidelines recommend total thyroidectomy for PTC tumors > 1 cm, based on older data demonstrating an overall survival advantage for total thyroidectomy over lobectomy. Methods: Adult patients with PTC tumors 1.0-4.0 cm undergoing thyroidectomy in the National Cancer Database, 1998-2006, were included. Cox proportional hazards models were applied to measure the association between the extent of surgery and overall survival while adjusting for patient demographic and clinical factors, including comorbidities, extrathyroidal extension, multifocality, nodal and distant metastases, and radioactive iodine treatment. Results: Among 61,775 PTC patients, 54,926 underwent total thyroidectomy and 6849 lobectomy. Compared with lobectomy, patients undergoing total thyroidectomy had more nodal (7% vs 27%), extrathyroidal (5% vs16%), and multifocal disease (29% vs 44%) (all Ps < 0.001). Median follow-up was 82 months (range, 60-179 months). After multivariable adjustment, overall survival was similar in patients undergoing total thyroidectomy versus lobectomy for tumors 1.0-4.0 cm [hazard ratio (HR) = 0.96; 95% confidence interval (CI), 0.84-1.09); P = 0.54] and when stratified by tumor size: 1.0-2.0 cm [HR = 1.05; 95% CI, 0.88-1.26; P = 0.61] and 2.1-4.0 cm [HR = 0.89; 95% CI, 0.73-1.07; P = 0.21]. Older age, male sex, black race, lower income, tumor size, and presence of nodal or distant metastases were independently associated with compromised survival (P < 0.0001). Conclusions: Current guidelines suggest total thyroidectomy for PTC tumors > 1 cm. However, we did not observe a survival advantage associated with total thyroidectomy compared with lobectomy. These findings call into question whether tumor size should be an absolute indication for total thyroidectomy.
引用
收藏
页码:601 / 607
页数:7
相关论文
共 21 条
[1]
DIFFERENTIATED CARCINOMA OF THE THYROID WITH EXTRATHYROIDAL EXTENSION [J].
ANDERSEN, PE ;
KINSELLA, J ;
LOREE, TR ;
SHAHA, AR ;
SHAH, JP .
AMERICAN JOURNAL OF SURGERY, 1995, 170 (05) :467-470
[2]
[Anonymous], 2013, Cancer Facts and Figures
[3]
The National Cancer Data Base: A powerful initiative to improve cancer care in the United States [J].
Bilimoria, Karl Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Ko, Clifford Y. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) :683-690
[4]
Extent of surgery affects survival for papillary thyroid cancer [J].
Bilimoria, Karl Y. ;
Bentrem, David J. ;
Ko, Clifford Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Talamonti, Mark S. ;
Sturgeon, Cord .
ANNALS OF SURGERY, 2007, 246 (03) :375-384
[5]
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[6]
Thyroid Cancer Survival in the United States Observational Data From 1973 to 2005 [J].
Davies, Louise ;
Welch, H. Gilbert .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 136 (05) :440-444
[7]
NATURAL-HISTORY, TREATMENT, AND COURSE OF PAPILLARY THYROID-CARCINOMA [J].
DEGROOT, LJ ;
KAPLAN, EL ;
MCCORMICK, M ;
STRAUS, FH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 71 (02) :414-424
[8]
ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]
Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989 [J].
Hay, ID ;
Bergstralh, EJ ;
Grant, CS ;
McIver, B ;
Thompson, GB ;
van Heerden, JA ;
Goellner, JR .
SURGERY, 1999, 126 (06) :1173-1181
[10]
Differentiated thyroid cancer: "Complete" rational approach [J].
Kebebew, E ;
Clark, OH .
WORLD JOURNAL OF SURGERY, 2000, 24 (08) :942-951